Trial Profile
Non-Interventional Observational Study With Viramune Plus ARV in HIV Infected Patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Nevirapine (Primary) ; Emtricitabine/tenofovir disoproxil fumarate; Lamivudine/abacavir; Lamivudine/zidovudine
- Indications HIV-1 infections
- Focus Adverse reactions
- Sponsors Boehringer Ingelheim Pharmaceuticals
- 09 Jan 2014 Status changed from active, no longer recruiting to completed; according to ClinicalTrials.gov.
- 07 Mar 2012 Planned end date changed from 1 Dec 2014 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 08 Feb 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.